Janet Stewart, MSc,  —

The U.S. Food and Drug Administration (FDA) has expanded approval of Dysport (abobotulinumtoxinA) for the treatment of lower limb spasticity in adults based on its supplemental Biologics License Application (sBLA), according to therapy developer Ipsen Biopharmaceuticals. Lower limb spasticity is a condition that affects many people in the United…

Children with cerebral palsy (CP) who did weight-bearing exercises for six months increased their bone mineral density (BMD) as well as bone growth, according to a Korean study, “The effect of weight bearing on bone mineral density and bone growth in children 
with cerebral palsy:
 A randomized controlled preliminary trial,” that appeared…